Intranasal bevacizumab in treating hereditary hemorrhagic telangiectasia associated epistaxis : long-term effectiveness and a novel correlation of Pentraxin 3 with epistaxis severity
Johan Steineger
Bok Engelsk 2002
Digital utgave: Søke-URL
Omfang | 1 bind (varierende paginering)
|
---|---|
Opplysninger | Avhandling (phd) - Universitetet i Oslo, 2020
|
Emner | Bevacizumab - administration & dosage : (DNLM)D000068258Q000008
Epistaxis - drug therapy : (DNLM)D004844Q000188 Patient Reported Outcome Measures : (DNLM)D000071066 Quality of Life : (DNLM)D011788 Vis mer... Telangiectasia, Hereditary Hemorrhagic - complications : (DNLM)D013683Q000150
Vascular Endothelial Growth Factors : (DNLM)D042442 Bevacizumab((DNLM)D000068258Q000008) - administration & dosage Epistaxis((DNLM)D004844Q000188) - drug therapy Telangiectasia, Hereditary Hemorrhagic((DNLM)D013683Q000150) - complications |
ISBN | 9788283776652
|